Atsushi Azumi Selected Research

Atsushi Azumi Research Topics

Disease

5	Inflammation (Inflammations) 02/2023 - 01/2008
4	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2024 - 01/2006
4	Uveitis 02/2023 - 01/2016
4	Retinal Detachment (Retinal Detachments) 01/2018 - 09/2012
3	Disease Progression 01/2021 - 10/2012
3	Immunoglobulin G4-Related Disease 09/2019 - 01/2012
2	Posterior Uveitis 02/2023 - 05/2012
2	Sarcoidosis (Schaumann Disease) 03/2022 - 01/2021
2	Glaucoma 03/2022 - 03/2012
2	Retinitis 03/2020 - 03/2003
2	Retinal Perforations 01/2017 - 09/2012
1	Orbital lymphoma 01/2024
1	Lymphoma (Lymphomas) 08/2023
1	Drug-Related Side Effects and Adverse Reactions 03/2022
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 03/2022
1	Thrombocytopenia chromosome breakage 01/2021
1	Granuloma 01/2021
1	Frontal Sinusitis 12/2020
1	Graves Ophthalmopathy 12/2020
1	Scotoma (Scintillating Scotoma) 03/2020
1	Infections 03/2020
1	Optic Nerve Diseases (Optic Neuropathy) 01/2020
1	Diplopia (Double Vision) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 09/2019
1	Vitreous Hemorrhage 01/2019
1	Thrombosis (Thrombus) 12/2018
1	Phlebitis 09/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2018
1	Optic Neuritis (Retrobulbar Neuritis) 09/2018
1	Pinealoma (Pineoblastoma) 09/2018
1	Retinal Vein Occlusion 01/2017
1	Macular Edema 01/2017
1	Neoplasms (Cancer) 01/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Leukoencephalopathies 01/2016
1	Posterior Leukoencephalopathy Syndrome 01/2016
1	Acute zonal occult outer retinopathy 11/2014
1	Macular Degeneration (Age-Related Maculopathy) 01/2014
1	Capillary Hemangioma 01/2014
1	Neoplasm Metastasis (Metastasis) 10/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012
1	Adenocarcinoma 10/2012
1	Choroidal Neovascularization 09/2012
1	Vasculitis (Vasculitides) 05/2012
1	Fever (Fevers) 05/2012
1	Dry Eye Syndromes (Dry Eye Syndrome) 03/2012
1	Cataract (Cataracts) 03/2012
1	Ocular Toxoplasmosis 01/2008
1	Protozoan Infections 01/2008
1	Melanoma (Melanoma, Malignant) 01/2006
1	Cutaneous Malignant Melanoma 01/2006

Drug/Important Bio-Agent (IBA)

6	SteroidsIBA 03/2022 - 09/2018
4	Retinaldehyde (Retinal)IBA 03/2020 - 01/2008
3	Immunoglobulin G (IgG)IBA 05/2024 - 01/2012
3	Ranibizumab (Lucentis)FDA Link 01/2017 - 09/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2024 - 08/2023
2	Hematoxylin (Haematoxylon)IBA 05/2024 - 08/2023
2	C-Reactive ProteinIBA 02/2023 - 05/2012
2	afliberceptIBA 01/2017 - 01/2014
1	ParaffinIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Cadherins (E-Cadherin)IBA 01/2024
1	VimentinIBA 01/2024
1	Formaldehyde (Formol)FDA Link 01/2024
1	Interleukin-6 (Interleukin 6)IBA 02/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2021
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2019
1	Peptides (Polypeptides)IBA 09/2019
1	AnticoagulantsIBA 12/2018
1	GadoliniumIBA 12/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	AntibodiesIBA 11/2014
1	Retinal Pigments (Pigments, Visual)IBA 01/2014
1	SolutionsIBA 01/2014
1	Timolol (Blocadren)FDA LinkGeneric 01/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2012
1	Tyrosine Kinase InhibitorsIBA 10/2012
1	Gefitinib (Iressa)FDA Link 10/2012
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2012
1	Coloring Agents (Dyes)IBA 05/2012
1	GlucocorticoidsIBA 01/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2006
1	Interferon-betaIBA 01/2006
1	CytokinesIBA 03/2003

Therapy/Procedure

7	Therapeutics 03/2020 - 01/2006
7	Vitrectomy 01/2019 - 01/2008
2	Decompression 12/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 09/2018 - 10/2012
2	Aftercare (After-Treatment) 05/2012 - 03/2012
2	Radiotherapy 03/2012 - 01/2006
1	Drug Tapering 09/2018
1	Intraocular Lens Implantation 01/2016
1	Scleral Buckling 01/2015
1	Cannula 01/2015